Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD
Clinical trial NCT02551172 · UNKNOWN
Trial details
- NCT number
- NCT02551172
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2016-01-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.